Sporadic colorectal cancer: Microbial contributors to disease prevention, development and therapy

British Journal of Cancer

Volumn 115, Issue 3, 2016, Pages 273-280

  Drewes, Julia L ^a   Housseau, Franck ^a   Sears, Cynthia L ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

biofilms; colorectal cancer; inflammasomes; inflammation; microbiota; pattern recognition receptors

Indexed keywords

ANTIBIOTIC AGENT; INFLAMMASOME; PATTERN RECOGNITION RECEPTOR;

ANTIBIOTIC SENSITIVITY; BIOFILM; CANCER GROWTH; CANCER PREVENTION; CARCINOGENESIS; COLORECTAL CANCER; HUMAN; IMMUNITY; INTESTINE FLORA; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYMBIOSIS; COLORECTAL NEOPLASMS; DISEASE COURSE; INTESTINE; MICROBIOLOGY; MICROFLORA;

COLORECTAL NEOPLASMS; DISEASE PROGRESSION; HUMANS; INTESTINES; MICROBIOTA;

EID: 84977138448     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2016.189     Document Type: Review

References (66)

1. Aries V, Crowther JS, Drasar BS, Hill MJ, Williams RE. (1969). Bacteria and the aetiology of cancer of the large bowel. Gut 10: 334-335
2. Arpaia N, Campbell C, Fan X, Dikiy S, Van Der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ, Rudensky AY. (2013). Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504: 451-455
3. Belladonna ML, Orabona C, Grohmann U, Puccetti P. (2009). TGF-beta and kynurenines as the key to infectious tolerance. Trends Mol Med 15: 41-49
4. Boleij A, Hechenbleikner EM, Goodwin AC, Badani R, Stein EM, Lazarev MG, Ellis B, Carroll KC, Albesiano E, Wick EC, Platz EA, Pardoll DM, Sears CL. (2015). The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin Infect Dis 60: 208-215
5. Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, Barnes R, Watson P, Allen-Vercoe E, Moore RA, Holt RA. (2012). Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 22: 299-306
6. Chae WJ, Gibson TF, Zelterman D, Hao L, Henegariu O, Bothwell AL. (2010). Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proc Natl Acad Sci USA 107: 5540-5544
7. Chen Y, Haines CJ, Gutcher I, Hochweller K, Blumenschein WM, McClanahan T, Hämmerling G, Li MO, Cua DJ, McGeachy MJ. (2011). Foxp3(±) regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2. Immunity 34: 409-421
8. Contractor N, Louten J, Kim L, Biron CA, Kelsall BL. (2007). Cutting edge: Peyer?s patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: possible role for IL-10, TGFbeta, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype. J Immunol 179: 2690-2694
9. Costerton JW, Stewart PS, Greenberg EP. (1999). Bacterial biofilms: a common cause of persistent infections. Science 284: 1318-1322
10. Couturier-Maillard A, Secher T, Rehman A, Normand S, De Arcangelis A, Haesler R, Huot L, Grandjean T, Bressenot A, Delanoye-Crespin A, Gaillot O, Schreiber S, Lemoine Y, Ryffel B, Hot D, Nùñez G, Chen G, Rosenstiel P, Chamaillard M. (2013). NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest 123: 700-711
11. Dejea CM, Wick EC, Hechenbleikner EM, White JR, Mark Welch JL, Rossetti BJ, Peterson SN, Snesrud EC, Borisy GG, Lazarev M, Stein E, Vadivelu J, Roslani AC, Malik AA, Wanyiri JW, Goh KL, Thevambiga I, Fu K, Wan F, Llosa N, Housseau F, Romans K, Wu X, McAllister FM, Wu S, Vogelstein B, Kinzler KW, Pardoll DM, Sears CL. (2014). Microbiota organization is a distinct feature of proximal colorectal cancers. Proc Natl Acad Sci USA 111: 18321-18326
12. Di Martino ML, Campilongo R, Casalino M, Micheli G, Colonna B, Prosseda G. (2013). Polyamines: emerging players in bacteria-host interactions. Int J Med Microbiol 303: 484-491
13. Dihlmann S, Tao S, Echterdiek F, Herpel E, Jansen L, Chang-Claude J, Brenner H, Hoffmeister M, Kloor M. (2014). Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients. Int J Cancer 135: 2387-2396
14. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. (2005). Diversity of the human intestinal microbial flora. Science 308: 1635-1638
15. Fearon ER, Vogelstein B. (1990). A genetic model for colorectal tumorigenesis. Cell 61: 759-767
16. Geis AL, Fan H, Wu X, Wu S, Huso DL, Wolfe JL, Sears CL, Pardoll DM, Housseau F. (2015). Regulatory T-cell response to enterotoxigenic Bacteroides fragilis colonization triggers IL17-dependent colon carcinogenesis. Cancer Discov 5: 1098-1109
17. Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, Taniguchi K, Yu GY, Osterreicher CH, Hung KE, Datz C, Feng Y, Fearon ER, Oukka M, Tessarollo L, Coppola V, Yarovinsky F, Cheroutre H, Eckmann L, Trinchieri G, Karin M. (2012). Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491: 254-258
18. Hill MJ, Drasar BS, Hawksworth G, Aries V, Crowther JS, Williams RE. (1971). Bacteria and aetiology of cancer of large bowel. Lancet 1: 95-100
19. Hu B, Elinav E, Huber S, Strowig T, Hao L, Hafemann A, Jin C, Wunderlich C, Wunderlich T, Eisenbarth SC, Flavell RA. (2013). Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proc Natl Acad Sci USA 110: 9862-9867
20. Hu S, Peng L, Kwak YT, Tekippe EM, Pasare C, Malter JS, Hooper LV, Zaki MH. (2015). The DNA sensor AIM2 maintains intestinal homeostasis via regulation of epithelial antimicrobial host defense. Cell Rep 13: 1922-1936
21. Hu W, Troutman TD, Edukulla R, Pasare C. (2011). Priming microenvironments dictate cytokine requirements for T helper 17 cell lineage commitment. Immunity 35: 1010-1022
22. Iida N, Dzutsev A, Stewart CA, Smith L, Bouladoux N, Weingarten RA, Molina DA, Salcedo R, Back T, Cramer S, Dai RM, Kiu H, Cardone M, Naik S, Patri AK, Wang E, Marincola FM, Frank KM, Belkaid Y, Trinchieri G, Goldszmid RS. (2013). Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science 342: 967-970
23. Irrazabal T, Belcheva A, Girardin SE, Martin A, Philpott DJ. (2014). The multifaceted role of the intestinal microbiota in colon cancer. Mol Cell 54: 309-320
24. Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. (2008). The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci USA 105: 15064-15069
25. Johnson CH, Dejea CM, Edler D, Hoang LT, Santidrian AF, Felding BH, Ivanisevic J, Cho K, Wick EC, Hechenbleikner EM, Uritboonthai W, Goetz L, Casero Jr RA, Pardoll DM, White JR, Patti GJ, Sears CL, Siuzdak G. (2015). Metabolism links bacterial biofilms and colon carcinogenesis. Cell Metab 21: 891-897
26. Kawakami H, Zaanan A, Sinicrope FA. (2015). Microsatellite instability testing and its role in the management of colorectal cancer. Curr Treat Options Oncol 16: 30
27. Levy M, Thaiss CA, Zeevi D, Dohnalova L, Zilberman-Schapira G, Mahdi JA, David E, Savidor A, Korem T, Herzig Y, Pevsner-Fischer M, Shapiro H, Christ A, Harmelin A, Halpern Z, Latz E, Flavell RA, Amit I, Segal E, Elinav E. (2015). Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling. Cell 163: 1428-1443
28. Liu R, Truax AD, Chen L, Hu P, Li Z, Chen J, Song C, Chen L, Ting JP. (2015). Expression profile of innate immune receptors, NLRs and AIM2, in human colorectal cancer: correlation with cancer stages and inflammasome components. Oncotarget 6: 33456-33469
29. Louis P, Hold GL, Flint HJ. (2014). The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 12: 661-672
30. Lu S, Bevier M, Huhn S, Sainz J, Lascorz J, Pardini B, Naccarati A, Vodickova L, Novotny J, Hemminki K, Vodicka P, Försti A. (2013). Genetic variants in C-type lectin genes are associated with colorectal cancer susceptibility and clinical outcome. Int J Cancer 133: 2325-2333
31. Luddy KA, Robertson-Tessi M, Tafreshi NK, Soliman H, Morse DL. (2014). The role of toll-like receptors in colorectal cancer progression: evidence for epithelial to leucocytic transition. Front Immunol 5: 429
32. Macfarlane S, Furrie E, Cummings JH, Macfarlane GT. (2004). Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis. Clin Infect Dis 38: 1690-1699
33. Man SM, Zhu Q, Zhu L, Liu Z, Karki R, Malik A, Sharma D, Li L, Malireddi RK, Gurung P, Neale G, Olsen SR, Carter RA, McGoldrick DJ, Wu G, Finkelstein D, Vogel P, Gilbertson RJ, Kanneganti TD. (2015). Critical role for the DNA sensor AIM2 in stem cell proliferation and cancer. Cell 162: 45-58
34. Mariathasan S, Weiss DS, Newton K, McBride J, Orourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM. (2006). Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228-232
35. Mima K, Nishihara R, Qian ZR, Cao Y, Sukawa Y, Nowak JA, Yang J, Dou R, Masugi Y, Song M, Kostic AD, Giannakis M, Bullman S, Milner DA, Baba H, Giovannucci EL, Garraway LA, Freeman GJ, Dranoff G, Garrett WS, Huttenhower C, Meyerson M, Meyerhardt JA, Chan AT, Fuchs CS, Ogino S. (2015a). Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut; e-pub ahead of print 26 August 2016; doi: 10.1136/gutjnl-2015-310101
36. Mima K, Sukawa Y, Nishihara R, Qian ZR, Yamauchi M, Inamura K, Kim SA, Masuda A, Nowak JA, Nosho K, Kostic AD, Giannakis M, Watanabe H, Bullman S, Milner DA, Harris CC, Giovannucci E, Garraway LA, Freeman GJ, Dranoff G, Chan AT, Garrett WS, Huttenhower C, Fuchs CS, Ogino S. (2015b). Fusobacterium nucleatum and T cells in colorectal carcinoma. JAMA Oncol 1: 653-661
37. Mira-Pascual L, Cabrera-Rubio R, Ocon S, Costales P, Parra A, Suarez A, Moris F, Rodrigo L, Mira A, Collado MC. (2015). Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J Gastroenterol 50: 167-179
38. Moon C, Baldridge MT, Wallace MA, Burnham CA, Virgin HW, Stappenbeck TS. (2015). Vertically transmitted faecal IgA levels determine extra-chromosomal phenotypic variation. Nature 521: 90-93
39. Natividad JM, Petit V, Huang X, De Palma G, Jury J, Sanz Y, Philpott D, Garcia Rodenas CL, McCoy KD, Verdu EF. (2012). Commensal and probiotic bacteria influence intestinal barrier function and susceptibility to colitis in Nod1-/-; Nod2-/- mice. Inflamm Bowel Dis 18: 1434-1446
40. Nonaka M, Ma BY, Imaeda H, Kawabe K, Kawasaki N, Hodohara K, Kawasaki N, Andoh A, Fujiyama Y, Kawasaki T. (2011). Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) recognizes a novel ligand, Mac-2-binding protein, characteristically expressed on human colorectal carcinomas. J Biol Chem 286: 22403-22413
41. Normand S, Delanoye-Crespin A, Bressenot A, Huot L, Grandjean T, Peyrin-Biroulet L, Lemoine Y, Hot D, Chamaillard M. (2011). Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc Natl Acad Sci USA 108: 9601-9606
42. Pallotta MT, Orabona C, Volpi C, Vacca C, Belladonna ML, Bianchi R, Servillo G, Brunacci C, Calvitti M, Bicciato S, Mazza EM, Boon L, Grassi F, Fioretti MC, Fallarino F, Puccetti P, Grohmann U. (2011). Indoleamine 2, 3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells. Nat Immunol 12: 870-878
43. Pandiyan P, Conti HR, Zheng L, Peterson AC, Mathern DR, Hernandez-Santos N, Edgerton M, Gaffen SL, Lenardo MJ. (2011). CD4(±)CD25(±)Foxp3(±) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 34: 422-434
44. Peuker K, Muff S, Wang J, Kunzel S, Bosse E, Zeissig Y, Luzzi G, Basic M, Strigli A, Ulbricht A, Kaser A, Arlt A, Chavakis T, van den Brink GR, Schafmayer C, Egberts JH, Becker T, Bianchi ME, Bleich A, Röcken C, Hampe J, Schreiber S, Baines JF, Blumberg RS, Zeissig S. (2016). Epithelial calcineurin controls microbiota-dependent intestinal tumor development. Nat Med
45. Philpott DJ, Sorbara MT, Robertson SJ, Croitoru K, Girardin SE. (2014). NOD proteins: regulators of inflammation in health and disease. Nat Rev Immunol 14: 9-23
46. Rakoff-Nahoum S, Medzhitov R. (2007). Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317: 124-127
47. Schoultz I, Verma D, Halfvarsson J, Torkvist L, Fredrikson M, Sjoqvist U, Lördal M, Tysk C, Lerm M, Söderkvist P, Söderholm JD. (2009). Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohn?s disease in Swedish men. Am J Gastroenterol 104: 1180-1188
48. Sears CL, Garrett WS. (2014). Microbes, microbiota, and colon cancer. Cell Host Microbe 15: 317-328
49. Sharma N, Jha S. (2015). NLR-regulated pathways in cancer: opportunities and obstacles for therapeutic interventions. Cell Mol Life Sci 73: 1741-1764
50. Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B, Alegre ML, Chang EB, Gajewski TF. (2015). Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350: 1084-1089
51. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly YM, Glickman JN, Garrett WS. (2013). The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341: 569-573
52. Smythies LE, Maheshwari A, Clements R, Eckhoff D, Novak L, Vu HL, Mosteller-Barnum LM, Sellers M, Smith PD. (2006). Mucosal IL-8 and TGF-beta recruit blood monocytes: evidence for cross-talk between the lamina propria stroma and myeloid cells. J Leukoc Biol 80: 492-499
53. Smythies LE, Sellers M, Clements RH, Mosteller-Barnum M, Meng G, Benjamin WH, Orenstein JM, Smith PD. (2005). Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 115: 66-75
54. Song X, Gao H, Lin Y, Yao Y, Zhu S, Wang J, Liu Y, Yao X, Meng G, Shen N, Shi Y, Iwakura Y, Qian Y. (2014). Alterations in the microbiota drive interleukin-17C production from intestinal epithelial cells to promote tumorigenesis. Immunity 40: 140-152
55. Swidsinski A, Loening-Baucke V, Herber A. (2009). Mucosal flora in Crohn?s disease and ulcerative colitis?an overview. J Physiol Pharmacol 60: 61-71
56. Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H. (2005). Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 43: 3380-3389
57. Tian Y, Li Y, Hu Z, Wang D, Sun X, Ren C. (2010). Differential effects of NOD2 polymorphisms on colorectal cancer risk: a meta-Analysis. Int J Colorectal Dis 25: 161-168
58. Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, Berger A, Bruneval P, Fridman WH, Pagès F, Galon J. (2011). Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 71: 1263-1271
59. Ungerback J, Belenki D, Jawad ul-Hassan A, Fredrikson M, Fransen K, Elander N, Verma D, Söderkvist P. (2012). Genetic variation and alterations of genes involved in NFkappaB/TNFAIP3-And NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer. Carcinogenesis 33: 2126-2134
60. Uronis JM, Muhlbauer M, Herfarth HH, Rubinas TC, Jones GS, Jobin C. (2009). Modulation of the intestinal microbiota alters colitis-Associated colorectal cancer susceptibility. PLoS One 4: e6026
61. Vetizou M, Pitt JM, Daillere R, Lepage P, Waldschmitt N, Flament C, Rusakiewicz S, Routy B, Roberti MP, Duong CP, Poirier-Colame V, Roux A, Becharef S, Formenti S, Golden E, Cording S, Eberl G, Schlitzer A, Ginhoux F, Mani S, Yamazaki T, Jacquelot N, Enot DP, Bérard M, Nigou J, Opolon P, Eggermont A, Woerther PL, Chachaty E, Chaput N, Robert C, Mateus C, Kroemer G, Raoult D, Boneca IG, Carbonnel F, Chamaillard M, Zitvogel L. (2015). Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350: 1079-1084
62. Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillere R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ, Schlitzer A, Ginhoux F, Apetoh L, Chachaty E, Woerther PL, Eberl G, Bérard M, Ecobichon C, Clermont D, Bizet C, Gaboriau-Routhiau V, Cerf-Bensussan N, Opolon P, Yessaad N, Vivier E, Ryffel B, Elson CO, Doré J, Kroemer G, Lepage P, Boneca IG, Ghiringhelli F, Zitvogel L. (2013). The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 342: 971-976
63. Wlodarska M, Thaiss CA, Nowarski R, Henao-Mejia J, Zhang JP, Brown EM, Frankel G, Levy M, Katz MN, Philbrick WM, Elinav E, Finlay BB, Flavell RA. (2014). NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell 156: 1045-1059
64. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, Silliman N, Szabo S, Dezso Z, Ustyanksky V, Nikolskaya T, Nikolsky Y, Karchin R, Wilson PA, Kaminker JS, Zhang Z, Croshaw R, Willis J, Dawson D, Shipitsin M, Willson JK, Sukumar S, Polyak K, Park BH, Pethiyagoda CL, Pant PV, Ballinger DG, Sparks AB, Hartigan J, Smith DR, Suh E, Papadopoulos N, Buckhaults P, Markowitz SD, Parmigiani G, Kinzler KW, Velculescu VE, Vogelstein B. (2007). The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113
65. Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, Huso DL, Brancati FL, Wick E, McAllister F, Housseau F, Pardoll DM, Sears CL. (2009). A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 15: 1016-1022
66. Yamauchi M, Morikawa T, Kuchiba A, Imamura Y, Qian ZR, Nishihara R, Liao X, Waldron L, Hoshida Y, Huttenhower C, Chan AT, Giovannucci E, Fuchs C, Ogino S. (2012). Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum. Gut 61: 847-854